Teyi Pharmaceutical Group Co Ltd (002728) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.025x

Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) has a cash flow conversion efficiency ratio of 0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.44 Million ≈ $6.65 Million USD) by net assets (CN¥1.80 Billion ≈ $263.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Teyi Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Teyi Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002728 total debt and obligations for a breakdown of total debt and financial obligations.

Teyi Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teyi Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Jinling Sports Equipment Co Ltd SHE:300651	0.053x
Tian Jin Global Magnetic Card Co Ltd SHG:600800	-0.002x
Gujarat Narmada Valley Fertilizers and Chemicals Limited NSE:GNFC	0.036x
Kri-Kri Milk Industry S.A AT:KRI	0.177x
Zhejiang He Chuan Technology Corp. Ltd. A SHG:688320	N/A
B Communications Ltd TA:BCOM	0.170x
COMSTOCK HLDG-A F:CHO	N/A
Shanghai Kinetic Medical Co SHE:300326	0.025x

Annual Cash Flow Conversion Efficiency for Teyi Pharmaceutical Group Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 002728 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.76 Billion ≈ $258.27 Million	CN¥-22.55 Million ≈ $-3.30 Million	-0.013x	-112.94%
2023-12-31	CN¥2.01 Billion ≈ $294.23 Million	CN¥198.56 Million ≈ $29.06 Million	0.099x	-62.72%
2022-12-31	CN¥1.40 Billion ≈ $205.32 Million	CN¥371.66 Million ≈ $54.39 Million	0.265x	+30.13%
2021-12-31	CN¥1.26 Billion ≈ $184.62 Million	CN¥256.81 Million ≈ $37.58 Million	0.204x	+30.14%
2020-12-31	CN¥1.08 Billion ≈ $158.10 Million	CN¥168.99 Million ≈ $24.73 Million	0.156x	-18.63%
2019-12-31	CN¥1.15 Billion ≈ $168.73 Million	CN¥221.64 Million ≈ $32.43 Million	0.192x	+13.64%
2018-12-31	CN¥1.11 Billion ≈ $162.60 Million	CN¥187.97 Million ≈ $27.51 Million	0.169x	+71.34%
2017-12-31	CN¥1.04 Billion ≈ $152.60 Million	CN¥102.96 Million ≈ $15.07 Million	0.099x	-13.59%
2016-12-31	CN¥886.57 Million ≈ $129.73 Million	CN¥101.30 Million ≈ $14.82 Million	0.114x	+33.44%
2015-12-31	CN¥804.30 Million ≈ $117.69 Million	CN¥68.87 Million ≈ $10.08 Million	0.086x	+9.84%
2014-12-31	CN¥735.64 Million ≈ $107.65 Million	CN¥57.35 Million ≈ $8.39 Million	0.078x	-63.23%
2013-12-31	CN¥350.14 Million ≈ $51.24 Million	CN¥74.23 Million ≈ $10.86 Million	0.212x	-42.12%
2012-12-31	CN¥285.34 Million ≈ $41.75 Million	CN¥104.50 Million ≈ $15.29 Million	0.366x	+18.31%
2011-12-31	CN¥225.51 Million ≈ $33.00 Million	CN¥69.81 Million ≈ $10.21 Million	0.310x	+12.70%
2010-12-31	CN¥170.81 Million ≈ $25.00 Million	CN¥46.92 Million ≈ $6.87 Million	0.275x	+26.99%
2009-12-31	CN¥103.18 Million ≈ $15.10 Million	CN¥22.32 Million ≈ $3.27 Million	0.216x	--

About Teyi Pharmaceutical Group Co Ltd

SHE:002728 China Drug Manufacturers - Specialty & Generic

Market Cap

$745.43 Million

CN¥5.09 Billion CNY

Market Cap Rank

#10512 Global

#3073 in China

Share Price

CN¥9.93

Change (1 day)

+0.00%

52-Week Range

CN¥8.04 - CN¥15.21

All Time High

CN¥129.24